Takeshi Koike’s latest take on Monkey Punch’s vintage manga thief is beautifully animated, but the gossamer-thin plot and characterisation mean it’s one for superfans only ...

Kripalu currently serves as executive director of EPL and previously served as its managing director and global CEO until Dec. 31, 2025 ...

Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.

Lupin Ltd (BOM:500257) reports robust financial performance with significant gains in the US market and emerging markets, despite challenges in India and competitive pressures.

Lupin Ltd reported a consolidated net profit of ₹1,175.6 crore in Q3 FY26, up 37.5% year-on-year, though down sequentially ...

Lupin resolves patent dispute with Astellas, agreeing to pay $90 million to continue selling Mirabegron for overactive ...

Zydus Lifesciences has reached a settlement agreement with Astellas in a patent dispute involving overactive bladder therapy Myrbetriq, which will allow its generic to remain on sale in the US.

Of the 40 analysts that have coverage on the Lupin stock, 28 have a 'buy' rating, nine have a 'hold' rating and three have a ...

Lupin, a leading drug firm, has signed a license and supply agreement with Spektus Pharma to commercialise the antidepressant DeslaFlex in Canada.

In a statement, Japan's Astellas said the specific terms of the settlement were confidential; however, a regulatory filing has revealed that the Indian pharma group has agreed to pay $90 million to ...

On Friday, a post on the official X (formerly Twitter) account for the Lupin the 3rd franchise announced a new animated movie set to come out next year. The film, tentatively titled Lupin the IIIrd ...